🇺🇸 FDA
Pipeline program

Experimental

IIT20240172C

Phase 2 small_molecule active

Quick answer

Experimental for Locally Advanced Rectal Cancer (LARC) is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Locally Advanced Rectal Cancer (LARC)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials